Citius Oncology Inc (CTOR)

Currency in USD
1.27
+0.02(+1.60%)
Closed·
1.31+0.04(+3.15%)
·
CTOR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.201.29
52 wk Range
0.556.19
Key Statistics
Prev. Close
1.25
Open
1.25
Day's Range
1.2-1.29
52 wk Range
0.55-6.19
Volume
386.04K
Average Volume (3m)
445.79K
1-Year Change
29.59%
Book Value / Share
0.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CTOR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.00
Upside
+372.44%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Citius Oncology Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Citius Oncology Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Compare CTOR to Peers and Sector

Metrics to compare
CTOR
Peers
Sector
Relationship
P/E Ratio
−4.1x−5.1x−0.6x
PEG Ratio
0.13−0.060.00
Price/Book
3.3x2.1x2.6x
Price / LTM Sales
-14.8x3.2x
Upside (Analyst Target)
380.0%127.5%41.8%
Fair Value Upside
Unlock2.2%5.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.00
(+372.44% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy6.00+372.44%-Upgrade23/09/2025
Maxim Group
Hold---Downgrade23/05/2025

Earnings

Latest Release
Aug 12, 2025
EPS / Forecast
-0.08 / -0.09
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

9.22
ENGN
+5.13%
8.11
LHAI
-16.82%
8.44
SGHT
0.00%
0.38
SAFX
-2.59%
2.430
CMND
-6.18%

FAQ

What Is the Citius Oncology (CTOR) Share Price Today?

The live Citius Oncology share price today is 1.27

What Stock Exchange Does Citius Oncology (CTOR) Trade On?

Citius Oncology is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Citius Oncology?

The stock symbol (also called a 'ticker') for Citius Oncology is "CTOR."

What Is the Current Citius Oncology Market Cap?

As of today, Citius Oncology market capitalisation is 107.69M.

What Is Citius Oncology's (CTOR) Earnings Per Share (TTM)?

The Citius Oncology EPS is currently -0.37 (Trailing Twelve Months).

Is CTOR a Buy or Sell From a Technical Analyst Perspective?

Based on today's Citius Oncology moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Citius Oncology Stock Split?

Citius Oncology has split 0 times. (See the CTOR stock split history page for full effective split date and price information.)

What is the current trading status of Citius Oncology (CTOR)?

As of 24 Dec 2025, Citius Oncology (CTOR) is trading at a price of 1.27, with a previous close of 1.25. The stock has fluctuated within a day range of 1.20 to 1.29, while its 52-week range spans from 0.55 to 6.19.

What Is Citius Oncology (CTOR) Price Target According to Analysts?

The average 12-month price target for Citius Oncology is USD6, with a high estimate of USD6 and a low estimate of USD6. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +372.44% Upside potential.

What Is the CTOR Premarket Price?

CTOR's last pre-market stock price is 1.26. The pre-market share volume is 7,700.00, and the stock has decreased by 0.01, or 0.80%.

What Is the CTOR After Hours Price?

CTOR's last after hours stock price is 1.31, the stock has decreased by 0.04, or 3.15%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.